News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,989 Results
Type
Article (8450)
Company Profile (78)
Press Release (283451)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (96802)
Career Advice (664)
Deals (16894)
Drug Delivery (13)
Drug Development (37900)
Employer Resources (49)
FDA (5299)
Job Trends (5812)
News (144227)
Policy (11405)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (754)
Accelerated approval (24)
ADA (13)
Allergies (94)
Alliances (21491)
ALS (106)
Alzheimer's disease (745)
Antibody-drug conjugate (ADC) (291)
Approvals (5783)
Artificial intelligence (289)
ASCO (136)
Autoimmune disease (193)
Automation (26)
Bankruptcy (115)
Best Places to Work (5022)
BIO (34)
BIOSECURE Act (3)
Biosimilars (147)
Biotechnology (55)
Bladder cancer (119)
Brain cancer (32)
Breast cancer (305)
Cancer (2779)
Cardiovascular disease (167)
Career advice (590)
Career pathing (17)
CAR-T (129)
CDC (5)
Celiac Disease (1)
Cell therapy (330)
Cervical cancer (25)
Clinical research (35243)
Collaboration (1094)
Compensation (925)
Complete response letters (25)
COVID-19 (787)
CRISPR (38)
C-suite (623)
Cystic fibrosis (58)
Data (4371)
Denatured (3)
Depression (103)
Dermatology (51)
Diabetes (255)
Diagnostics (1935)
Digital health (28)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (131)
Drug pricing (27)
Drug shortages (6)
Duchenne muscular dystrophy (138)
Earnings (39163)
Editorial (8)
Employer branding (6)
Employer resources (47)
Events (51103)
Executive appointments (571)
FDA (7312)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (3)
Frontotemporal dementia (18)
Funding (748)
Gene editing (79)
Generative AI (24)
Gene therapy (202)
GLP-1 (342)
Government (1139)
Grass and pollen (1)
Guidances (229)
Healthcare (6105)
Hematology (93)
HIV (38)
Huntington's disease (13)
IgA nephropathy (52)
Immunology and inflammation (70)
Immuno-oncology (39)
Indications (121)
Infectious disease (916)
Inflammatory bowel disease (103)
Inflation Reduction Act (1)
Influenza (59)
Intellectual property (145)
Interviews (112)
IPO (8708)
IRA (8)
Job creations (1017)
Job search strategy (497)
JPM (7)
Kidney cancer (13)
Labor market (23)
Layoffs (101)
Leadership (19)
Legal (2567)
Liver cancer (49)
Longevity (12)
Lung cancer (405)
Lymphoma (234)
Machine learning (29)
Management (19)
Manufacturing (464)
Marketing (2)
MASH (132)
Medical device (4168)
Medtech (4230)
Mergers & acquisitions (9060)
Metabolic disorders (638)
mRNA (49)
Multiple sclerosis (96)
NASH (8)
Neurodegenerative disease (159)
Neuropsychiatric disorders (42)
Neuroscience (1527)
NextGen: Class of 2026 (2094)
Non-profit (1438)
Now hiring (7)
Obesity (225)
Opinion (73)
Ovarian cancer (88)
Pain (109)
Pancreatic cancer (153)
Parkinson's disease (177)
Partnered (14)
Patents (268)
Patient recruitment (383)
Peanut (28)
People (24468)
Pharmaceutical (25)
Pharmacy benefit managers (7)
Phase 1 (10429)
Phase 2 (15758)
Phase 3 (11896)
Pipeline (5343)
Policy (49)
Postmarket research (769)
Preclinical (3907)
Press Release (18)
Prostate cancer (122)
Psychedelics (7)
Radiopharmaceuticals (161)
Rare diseases (484)
Real estate (1982)
Recruiting (22)
Regulatory (10181)
Reports (23)
Research institute (645)
Resumes & cover letters (82)
Rett syndrome (9)
RNA editing (8)
RSV (26)
Schizophrenia (135)
Series A (126)
Series B (93)
Service/supplier (5)
Sickle cell disease (42)
Special edition (1)
Spinal muscular atrophy (56)
Sponsored (13)
Startups (1351)
State (1)
Stomach cancer (3)
Supply chain (44)
Tariffs (11)
The Weekly (1)
Vaccines (291)
Venture capital (27)
Weight loss (78)
Women's health (38)
Worklife (10)
Date
Last 7 days (196)
Last 30 days (907)
Last 365 days (14937)
2026 (8260)
2025 (14778)
2024 (17036)
2023 (19808)
2022 (25010)
2021 (27101)
2020 (24544)
2019 (18790)
2018 (13681)
2017 (13793)
2016 (12222)
2015 (15077)
2014 (11378)
2013 (8627)
2012 (8773)
2011 (8773)
2010 (8242)
Location
Africa (239)
Alabama (33)
Alaska (2)
Arizona (99)
Arkansas (7)
Asia (30684)
Australia (3896)
California (6885)
Canada (1765)
China (1224)
Colorado (254)
Connecticut (412)
Delaware (270)
Europe (40693)
Florida (1043)
Georgia (211)
Idaho (10)
Illinois (491)
India (61)
Indiana (228)
Iowa (18)
Japan (436)
Kansas (87)
Kentucky (20)
Louisiana (20)
Maine (20)
Maryland (718)
Massachusetts (5325)
Michigan (95)
Minnesota (291)
Mississippi (4)
Missouri (81)
Montana (1)
Nebraska (11)
Nevada (49)
New Hampshire (20)
New Jersey (2175)
New Mexico (7)
New York (2138)
North Carolina (867)
North Dakota (1)
Northern California (3584)
Ohio (158)
Oklahoma (12)
Oregon (14)
Pennsylvania (1310)
Puerto Rico (9)
Rhode Island (23)
South America (328)
South Carolina (13)
Southern California (2795)
Tennessee (56)
Texas (1030)
United States (24654)
Utah (180)
Vermont (1)
Virginia (279)
Washington D.C. (28)
Washington State (445)
West Virginia (2)
Wisconsin (48)
291,989 Results for "suzhou connect biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
June 18, 2026
·
4 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
July 10, 2026
·
10 min read
Press Releases
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
·
2 min read
Press Releases
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 13, 2026
·
1 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - July 6, 2026
July 6, 2026
·
2 min read
Press Releases
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise
June 22, 2026
·
6 min read
Press Releases
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
·
12 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - June 29, 2026
June 29, 2026
·
2 min read
Press Releases
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
June 17, 2026
·
10 min read
1 of 29,199
Next
